Drug Eluting Stents Market 2025 | Size, Share, Opportunities and Forecast | Credence Research

The global drug eluting stents market was valued at US$ 5,130.9 Mn in 2016, and is expected to reach US$ 8,377.9 Mn by 2025 expanding at a CAGR of 5.67 % from 2017 to 2025.

SANJOSE, United States - April 1, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. "Drug Eluting Stents Market-Growth, Future Prospects, Competitive Analysis, 2017-2025," the global market for drug eluting stents, valued at US$ 5,130.9 million in 2016, is expected to reach US$ 8,377.9 million by 2025, expanding to a CAGR of 5.67 percent from 2017 to 2025.

Manufacturers actively involved in the production of drug eluting stents focus primarily on three important parameters that are; metal structure that is usually made of stainless steel or chromium, cobalt alloy containing nickel that provides tensile strength and is non-leachable. The polymer that encapsulated the drug and controls its release at the implant to reduce local inflammation. The drug involved in the suppression of neointima hyperplasia. The cardiac surgeons while selecting a stent to achieve precise placement consider the dimensions of stents such as correct stent length matching the length of lesion, stent diameter matching diameter of the artery and sufficient deployment of stent to ensure full expansion of stent against the arterial wall to prevent adverse events such as restenosis and blood clots.

Don't miss out on business opportunities in Drug Eluting Stents Market

For customization and more Inquiry visit @ https://www.credenceresearch.com/inquiry-before-buying/58866

The inherent features of micro porous surface stents such as faster drug eluting rate and higher drug loading capacity of nanoporous surfaces are responsible for the polymer-free coating stents dominating the product segment. The polymer-based coating stents are in demand due to extended therapeutic efficacy and its smooth surface inhibiting the formation of neointima hyperplasia at the implant. In the applications segment, coronary heart disease highlights its prominent presence as the associated drivers contributing to its growth are poor health conditions such as binge drinking and smoking and increased circulation of c reactive proteins. Peripheral artery diseases are on the rise as patients with type 2 diabetes show symptoms of erectile dysfunction, poor healing rate of wounds, and claudication while walking.

North America has a strong foothold in the market of drug eluting stents related to drivers such as rising cardiac complications, obesity, and unhealthy lifestyle. Owing to the competitive market created due to the presence of existing and budding pharmaceutical companies manufacturing drug eluting stents, Asia Pacific will record an outstanding growth during the period 2015-2025. The drug eluting stents market comprises of the major players which are Biotronik, Biosensors International Group, Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Stentys, Medtronics Plc, Terumo Medical Corporation, Shandong JW Medical Systems and Lepu Medical Technology.

Key market movements:
Increasing the prevalence of cardiovascular complications such as heart attack and stroke.
Increasing public health awareness and increased government funding in the establishment of healthcare institutions with cardiac treatment centers
Supportive regulatory environment for drug eluting products

Get Sample (Free)@ https://www.credenceresearch.com/sample-request/58866

ToC:
Chapter 1. Preface
..............
Chapter 2. Executive Summary
...............
Chapter 3. Drug Eluting Stents Market: Dynamics and Future Outlook
.................
Chapter 4. Global Drug Eluting Stents Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Product, 2016
4.3. Polymer Based Coating
4.3.1. Non-Biodegradable Polymer Based
4.3.2. Biodegradable Polymer Based
4.4. Polymer Free Coating
4.4.1. Micro Porous Surface
4.4.2. Microstructured Surface
4.4.3. Slotted Tubular Surface
4.4.4. Nanoporous Surface

Chapter 5. Global Drug Eluting Stents Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Drug Eluting Stents Market, by Application, 2016
5.2. Peripheral Artery Disease
5.3. Coronary Artery Disease

Chapter 6. Global Drug Eluting Stents Market, by Geography, 2015 – 2025 (US$ Mn)
.............
Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Biosensors International Group
7.3. Biotronik
7.4. Boston Scientific Corporation
7.5. Cook Medical
7.6. Lepu Medical Technology
7.7. Medtronics Plc
7.8. Terumo Medical Corporation
7.9. Shandong JW Medical Systems
7.10. Stentys
................................toc continued

Browse the full report Drug Eluting Stents Market - Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at https://www.credenceresearch.com/report/drug-eluting-stents-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/drug-eluting-stents-market-2025-size-share-opportunities-and-forecast-credence-research/497493

Source: MarketersMedia

Release ID: 497493